Skip to main content
logo
Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS · Delayed Price · Currency is USD
0.0869
-0.0031 (-3.44%)
Aug 24, 2026, 3:11 PM EST

KBLB Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-3.69-3.37-3.07-2.61-2.12-2.76
Net Income
-4.15-3.62-3.4-3.03-3.84-8.05
Earnings Per Share
-0.00-0.00-0.00-0.00-0.00-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.391.790.672.553.962.36
Total Debt
1.691.661.71.751.772.42
Net Cash (Debt)
1.710.13-1.030.82.19-0.07
Net Cash Growth
----63.30%--
Net Cash Per Share
0.000.00-0.000.000.00-0.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.04-1.79-1.84-1.24-1.89-1.8
Capital Expenditures
-0.04-0.01-0-0.01-0.01-0.1
Free Cash Flow
-2.08-1.79-1.84-1.25-1.89-1.9
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------